International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1
Articolo
Data di Pubblicazione:
2012
Citazione:
International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1 / Giorgio V., S., Ihor, V., Keunchil, P., Yukito, I., Kaoru, K., Fiona, B., Robert, P., Rinat, G., Tudor Eliade, C., Oleksandr, S., Mircea, D., Zsolt Papai, S., Natividad Martinez, B., Sheryl, M., Bin, Y., Yong jiang, H., Galimi, F., David R., S.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 30:23(2012), pp. 2829-2836. [10.1200/JCO.2011.41.4987]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Giorgio V., Scagliotti; Ihor, Vynnychenko; Keunchil, Park; Yukito, Ichinose; Kaoru, Kubota; Fiona, Blackhall; Robert, Pirker; Rinat, Galiulin; Tudor Eliade, Ciuleanu; Oleksandr, Sydorenko; Mircea, Dediu; Zsolt Papai, Szekely; Natividad Martinez, Banaclocha; Sheryl, Mccoy; Bin, Yao; Yong jiang, Hei; Galimi, Francesco; David R., Spigel
Link alla scheda completa:
Pubblicato in: